Chemical modification and carrier interactions can slow clearance or proteolysis, but every half-life strategy may also alter potency, distribution, aggregation or analytical complexity.
Clearance and degradation are separate levers
Protease susceptibility, renal filtration, receptor-mediated uptake and nonspecific distribution can each shorten exposure. A modification should be linked to the mechanism it is intended to change rather than described only as long acting.
Common engineering approaches
Lipidation, polymer conjugation, albumin interaction, Fc or protein fusion and sequence stabilization change molecular size or interactions. These approaches can improve persistence while changing solubility, binding kinetics and tissue distribution.
Matched characterization
Modified and parent peptides should be compared for identity, purity, aggregation, target activity and relevant disposition parameters. A longer measured half-life is not by itself evidence that every functional property was preserved.
